Following publication of this article, the authors realized there was an error in Figure 2b that needed correction. The TFEB panel of Figure 2b (total lysate) appears to be the same as the TFEB panel of Figure 2e (cytosolic fraction); the TFE3 panels of Figure 2b (total lysate) appear to be the same as the TFE3 panels of Figure 2e (cytosolic fraction) which happened during image assembly.This error did not impact the scientific conclusions of the article.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776641 | PMC |
| http://dx.doi.org/10.1038/s41419-019-1981-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incidental Detection of -Amplified Renal Cell Carcinoma by Colocated Gene Amplification of (6p21): A Case Report and Review of the Literature.
Int J Surg Pathol
May 2024
University of Utah, Department of Pathology, Salt Lake City, UT, USA.
-amplified renal cell carcinoma (RCC), which belongs to the MITF family of RCC, is characterized by genomic amplification at the 6p21.1 locus where the gene is located. The vascular endothelial growth factor A and cyclin D3 genes are also located at this same locus.
View Article and Find Full Text PDFA Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
Cancers (Basel)
March 2023
Josep Carreras Leukaemia Research Institute (IJC), 08916 Barcelona, Spain.
Acute myeloid leukemia (AML) is a heterogeneous hematological cancer characterized by poor prognosis and frequent relapses. Aside from specific mutation-related changes, in AML, the overall function of lysosomes and mitochondria is drastically altered to fulfill the elevated biomass and bioenergetic demands. On the basis of previous results, in silico drug discovery screening was used to identify a new family of lysosome-/mitochondria-targeting compounds.
View Article and Find Full Text PDFTFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
Virchows Arch
December 2022
Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy.
TFE3/TFEB-rearranged renal cell carcinomas are characterized by translocations involving TFE3 and TFEB genes. Despite the initial description of typical morphology, their histological spectrum is wide, mimicking common subtypes of renal cell tumors. Thus, the diagnosis is challenging requiring the demonstration of the gene rearrangement, usually by FISH.
View Article and Find Full Text PDFNintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells.
Front Cell Dev Biol
March 2022
Department of Thoracic Surgery, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.
Malignant pleural mesothelioma (MPM) is a rare type of cancer with a grim prognosis. So far, no targetable oncogenic mutation was identified in MPM and biomarkers with predictive value toward drug sensitivity or resistance are also lacking. Nintedanib (BIBF1120) is a small-molecule tyrosine kinase inhibitor that showed promising efficacy preclinically and in phase II trial in MPM as an angiogenesis inhibitor combined with chemotherapy.
View Article and Find Full Text PDFRenal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases.
Histopathology
May 2022
Sorbonne Université, Assistance Publique Hôpitaux de Paris, Hôpital Armand Trousseau, Paris, France.
Aims: Renal cell carcinomas (RCCs) represent 2-5% of kidney malignancies in children and adolescents. Appropriate diagnostic and classification are crucial for the correct management of the patients and in order to avoid inappropriate pre-operative chemotherapy, which is usually recommended if a Wilms' tumour is suspected.
Methods And Results: A French-Italian series of 93 renal cell carcinomas collected from 1990 to 2019 in patients aged less than 18 years was reclassified according to the 2016 World Health Organization (WHO) classification and the latest literature.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!